Get Started for FREE
Sign up with Facebook Sign up with Twitter
I don't have a Facebook or a Twitter account
|
Scooped by
Curated by A4BC.ORG
onto Breast Cancer News |
Scoop.it!
Women being treated for breast cancer with anthracycline chemotherapy experienced less cardiotoxicity if they also were receiving statins, researchers found.
 Your new post is loading...
Scoop.it!
A blood test for cancer DNA could predict in two to three weeks if a new drug is responding to breast cancer, according to researchers in Britain.
Scoop.it!
Humana recently reclassified Herceptin — an intravenous drug used to treat metastatic breast cancer — as a nonpreferred drug in some Florida markets, CBS12 reports.
Curated by A4BC.ORG's insight:
Many patients are impacted negatively by the actions of Human. Once again this pharmaceutical company is putting big profits and causing financial toxicity to people that need this drug to stay alive.
Scoop.it!
Rather than marking a breakthrough in breast cancer treatment, the approval of neratinib marks an eroding of FDA standards. Puma received accelerated approval for neratinib based largely on a single phase III clinical trial, which showed that women with early stage HER2+ breast cancer were slightly
Scoop.it!
Authors discuss the evolution of the liquid biopsy in the detection and treatment of breast cancer.
Curated by A4BC.ORG's insight:
News from ASCO 2017 talking about the future of liquid biopsies for all stages of breast cancer
Scoop.it!
If you are a music fan or hear the news, by this time you must have come across this very disheartening news that Olivia Newton John’s breast cancer ha
Curated by A4BC.ORG's insight:
Wonderful article by Dr. Uzma Yunus explaining Metastatic Breast Cancer relating to Olivia Newton John's breast cancer that has spread to the bones
Scoop.it!
A new study shows that 83% of the largest patient advocacy groups take contributions from drug, medical device or biotech firms.
Curated by A4BC.ORG's insight:
There are many reasons why patient advocate organizations need money. We have never taken any from money from drug companies because we are trying to advocate for change in the industry especially for drug advertising money. There's no judgement, because without pharmaceutical money we have less ability to raise funds.
Scoop.it!
Sheryl Crow is promoting a specific brand of breast cancer screening device with simplistic slogans and trumped-up statistics. That's not ok.
Curated by A4BC.ORG's insight:
Gary's article tells the reality. What Sheryl is doing is wrong.
Scoop.it!
Cancer patients increasingly delay or skip taking medication because they can't afford it. New drugs that can cost $100,000 or more a year mean more people suffering "financial toxicity."
Curated by A4BC.ORG's insight:
This is so upsetting. The cost of drugs is out of control.
Scoop.it!
Lingerie and loungewear label AnaOno, which caters to breast cancer survivors, showcased the beauty and strength of its clientele on its Spring 2017 runway.
Curated by A4BC.ORG's insight:
So proud of the AnaOno lingerie and loungewear label strutting their stuff on the NYFW Runway catering to breast cancer survivors!
Scoop.it!
Curated by A4BC.ORG's insight:
Check out the great work being done at Living Beyond Breast Cancer
Scoop.it!
Experts, from the University of California San Francisco, found in 58 per cent of trials the lead investigator had at least some degree of financial tie to the firm that made the drug being tested.
Scoop.it!
A new breathalyzer can detect 17 different diseases, including pre-eclampsia and chronic kidney disease, from a single breath.
Curated by A4BC.ORG's insight:
To see the original study go to: http://pubs.acs.org/doi/full/10.1021/acsnano.6b04930
Scoop.it!
City of Hope patient Susan Young - diagnosed with late-stage triple negative breast cancer - has had a remarkable response to a revolutionary new treatment, a combination of the p53 cancer vaccine and a drug that blocks a specific cancer-aiding...
Curated by A4BC.ORG's insight:
This is truly remarkable. Hopefully it can help more people.
Irina Bcra's curator insight,
December 27, 2016 3:37 AM
We are an independent charity that supports innovative breast cancer research across the UK. We aim to help beat breast cancer and save lives by supporting ground-breaking research. Through our fundraising we support research organisations to develop and run breast cancer research programmes. These programmes enable huge steps to be taken in improving the prevention and treatment of breast cancer – the most common type of cancer in the UK.
Irina Bcra's curator insight,
April 25, 2017 8:29 AM
We are an independent charity that supports innovative breast cancer research across the UK. We aim to help beat breast cancer and save lives by supporting ground-breaking research. Through our fundraising we support research organisations to develop and run breast cancer research programmes. These programmes enable huge steps to be taken in improving the prevention and treatment of breast cancer – the most common type of cancer in the UK.
|
Scoop.it!
Within a complex and expensive health system, there are ways to cut both individual and societal costs without harming the quality of care.
Scoop.it!
Drug company Insys faked cancer patients to sell fentanyl drug Subsys according to Congressional investigation by Claire McCaskill of Missouri
Scoop.it!
A study by the University of Zurich shows how similar mammary tumors are in humans and dogs and how this can help aid cancer research.
Scoop.it!
The stakeholder group in healthcare that has been the most reluctant to adopt and to engage on social media is arguably pharma. Cultural and regulatory con
Scoop.it!
Although the odds of developing breast cancer are nearly identical for black and white women, black women are 42 percent more likely to die from the disease. This mortality gap—driven by social and environmental, as well as biological factors—continues to persist.
Scoop.it!
Doctors and drug developers have a stake in making cancer treatments seem better than they really are.
Curated by A4BC.ORG's insight:
Here is another excellent article by Liz Szabo explaining the hype that goes with cancer while drug companies continue to profit by spending on advertising commercials.
Scoop.it!
Despite the belief cancer is usually inherited or triggered by lifestyles, two thirds of cases can be put down to DNA errors, experts from Johns Hopkins Kimmel Cancer Center claim.
Curated by A4BC.ORG's insight:
While this article lacks scientific sources, the headline and information are true! Many people with healthy lifestyles get cancer. It would be nice to have more investigation and studies presented to the public, because there are many cancer patients who got the disease with healthy lifestyles. The point is no matter what stage and/or type of cancer, there are so many factors to what caused the disease and possible outcomes. It's time people understood that cancer is a genetic disease, and at all stages blaming a patient for their disease no matter what life style, needs to stop. Also within the cancer community, the war of the stages and types needs to stop.
Scoop.it!
As it readies for battle with President Trump over drug prices, the pharmaceutical industry is deploying economists and health care experts from the nation’s top universities. In scholarly articles, blogs and conferences, they lend their prestige to the lobbying blitz, without always disclosing thei
Curated by A4BC.ORG's insight:
This article is long but well worth reading. It makes one wonder why the pharmaceutical industry practices in the US has never been part of the conversation of how we can improve the Affordable Care Act.
Scoop.it!
MarginProbe, which checks tumor's edges while lumpectomy patient is still on operating table, is already in use in over 100 US hospitals
Curated by A4BC.ORG's insight:
While the article is overpraising the device as eliminating the need for follow up surgery since no device can ever predict that, it still is a great new tool.
Scoop.it!
In a study, scientists identified the enzymes LATS1 and LATS2 as key in the development and treatment of estrogen receptor-positive breast cancer.
Scoop.it!
A new study of Danish women suggests that screening mammography detects many tumors that might not have ever harmed women.
Curated by A4BC.ORG's insight:
So the debate continues about mammograms. This article looks at both sides of the issue,. Rita Rubin writes about the factors where screening could be ineffective, yet recognizing that the biggest problem is that they still don't know which tumors are going to spread. The article also recognizes the metastatic breast cancer problem as the deaths just keep coming.. With MBC we have to do better.
Scoop.it!
Curated by A4BC.ORG's insight:
What a terrible cancer scam rip off!
Irina Bcra's curator insight,
December 27, 2016 3:37 AM
We are an independent charity that supports innovative breast cancer research across the UK. We aim to help beat breast cancer and save lives by supporting ground-breaking research. Through our fundraising we support research organisations to develop and run breast cancer research programmes. These programmes enable huge steps to be taken in improving the prevention and treatment of breast cancer – the most common type of cancer in the UK. |
